Skip to main content
. 2026 Aug 17;64(8):myag083. doi: 10.1093/mmy/myag083

Table 3.

Distribution of isolates showing MIC values above the applicable interpretive threshold (AT) by yeast species and antifungal agent. Only species-drug combinations for which cutoff values (ECVs) were available are included.

Species FCZ1 AT/total (%) ITZ2 AT/total (%) VOR3 AT/total (%) PSZ4 AT/total (%) AND5 AT/total (%) AMB6 AT/total (%) Overall AT/total (%)
Candida orthopsilosis 2/2 (100%)* 2/2 (100%)* 2/2 (100%)* 2/2 (100%)* 0/2 (0%)* 2/2 (100%)* 10/12 (83.3%)
Candida parapsilosis 6/6 (100%) 6/6 (100%)* 0/6 (0%) 6/6 (100%)* 0/6 (0%) 6/6 (100%)* 24/36 (66.7%)
Clavispora lusitaniae 4/5 (80%)* 2/5 (40%)* – 5/5 (100%)* Intrinsic Intrinsic 21/25 (84%)
Meyerozyma guilliermondii 11/19 (57.9%)* 6/19 (31.6%)* – 16/19 (84.2%)* 2/19 (10.5%) 18/19 (94.7%)* 53/95 (55.8%)
Pichia kudriavzevii Intrinsic# 1/1 (100%)* 0/1 (0%) 1/1 (100%)* 1/1 (100%) – 4/5 (80%)
Wickerhamomyces anomalus 3/3 (100%)* 3/3 (100%)* 3/3 (100%)* 3/3 (100%)* – 3/3 (100%)* 15/15 (100%)
Pichia kluyveri – – – – – 2/4 (50%)* 2/4 (50%)
Trichosporon asahii – – – – 6/6 (100%)* – 6/6 (100%)
*

ECV-based classification; #Recognized intrinsic resistance for the combination, with all strains considered as above-threshold.

FCZ1, fluconazole; ITZ2, itraconazole; VOR3, voriconazole; PSZ4, posaconazole; AND5, anidulafungin; AMB6, amphotericin B.